PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cardiology, Department of Medicine (K.W., A.N., G.Y.O.), University of Alberta, Edmonton, Canada.\', \'Mazankowski Alberta Heart Institute (K.W., M.G., A.N., G.Y.O.), University of Alberta, Edmonton, Canada.\', \'Department of Physiology (M.G., Z.K., G.Y.O.), University of Alberta, Edmonton, Canada.\', \'Department of Critical Care Medicine (M.M., E.M., W.S.), University of Alberta, Edmonton, Canada.\', \'Division of Respirology, Department of Medicine (E.M.), University of Alberta, Edmonton, Canada.\', \'Division of Infectious Diseases, Department of Medicine (C.O., W.S.), University of Alberta, Edmonton, Canada.\', \'Attoquant Diagnostics, Vienna, Austria (M.P.).\', \'Pathology Unit, National Institute for Infectious Diseases \'Lazzaro Spallanzani,\' IRCCS, Rome, Italy (D.C., F.D.N.).\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1161/HYPERTENSIONAHA.121.18295
?:hasPublicationType
?:journal
  • Hypertension (Dallas, Tex. : 1979)
is ?:pmid of
?:pmid
?:pmid
  • 34844421
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all